Results
24,511 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 11 | Inrig JulaEVP, Head of R&D & CMO |  TVTXTravere Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $102K 1,600 sh | Sep 17, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 11 | Inrig JulaEVP, Head of R&D & CMO | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $102K 1,600 sh | Sep 17, 2026 |
| 11 | DiPerna DinoEVP & Chief R&D Officer |  CIENCIENA CORPOpen-market sale · 10b5-1 plan | SELL | $81K 249 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 11 | Misra AmitabhChief Technology Officer |  CXMSprinklr, Inc.Open-market sale · 10b5-1 plan | SELL | $164K 29.6K sh | Sep 17, 2026 traded Sep 16, 2026 |
| 11 | Cline Christopher R.CHIEF FINANCIAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $121K 1,900 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 11 | Calvin SandraSVP, CHIEF ACCOUNTING OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $19K 300 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 9 | Moore Alexander D.Director |  PLTRPalantir Technologies Inc.Open-market sale · 10b5-1 plan | SELL | $323K 1,843 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 9 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $401K 2,319 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 9 | Choudary Kiran KumarChief Financial Officer |  RBRKRubrik, Inc.Open-market sale · 10b5-1 plan | SELL | $293K 2,728 sh | Sep 17, 2026 traded Sep 17, 2026 |
| 9 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $278K 2,572 sh | Sep 17, 2026 traded Sep 17, 2026 |
| 9 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $687K 3,990 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 9 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $371K 2,129 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 9 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $667K 3,901 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 8 | Tariq MusaDirector |  GHGuardant Health, Inc.Open-market sale · 10b5-1 plan | SELL | $20K 116 sh | Sep 17, 2026 traded Sep 16, 2026 |
| 8 | Kenneweg JohnSVP, Sales & Product Marketing |  MASS908 Devices Inc.Open-market sale · 10b5-1 plan | SELL | $54K 5,257 sh | Sep 17, 2026 traded Sep 17, 2026 |
| 8 | Fordyce MarshallDirector, PRESIDENT AND CEO |  VERAVera Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $685K 18.5K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 8 | Inrig JulaEVP, Head of R&D & CMO | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $26K 400 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 8 | Cline Christopher R.CHIEF FINANCIAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $26K 400 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 8 | Hanson Scott McLeanDirector, Chief Technology Officer |  AMBQAmbiq Micro, Inc.Open-market sale · 10b5-1 plan | SELL | $6,100 100 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 6 | Kenneweg JohnSVP, Sales & Product Marketing | MASS908 Devices Inc. Open-market sale · 10b5-1 plan | SELL | $10K 1,000 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 6 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $109K 1,100 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 6 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $59K 586 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 6 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $72K 700 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 6 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $90K 510 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 6 | Moore Alexander D.Director | PLTRPalantir Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $223K 1,308 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 6 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $123K 1,214 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 4 | Holme TimothyCHIEF TECHNOLOGY OFFICER |  QSQuantumScape CorpOpen-market sale · 10b5-1 plan | SELL | $382K 75.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner |  CRCTCricut, Inc.Open-market sale · 10b5-1 plan | SELL | $333K 60.0K sh | Sep 17, 2026 traded Sep 16, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | CRCTCricut, Inc. Open-market sale · 10b5-1 plan | SELL | $341K 60.0K sh | Sep 17, 2026 traded Sep 17, 2026 |
| 4 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | CRCTCricut, Inc. Open-market sale · 10b5-1 plan | SELL | $337K 60.0K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 3 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $32K 300 sh | Sep 17, 2026 traded Sep 17, 2026 |
| 3 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $21K 200 sh | Sep 17, 2026 traded Sep 17, 2026 |
| 3 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 400 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 3 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $20K 200 sh | Sep 17, 2026 traded Sep 17, 2026 |
| 1 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS |  TBPHTheravance Biopharma, Inc.Open-market sale · 10b5-1 plan | SELL | $113K 6,657 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 1 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | TBPHTheravance Biopharma, Inc. Open-market sale · 10b5-1 plan | SELL | $57K 3,328 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 1 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | TBPHTheravance Biopharma, Inc. Open-market sale · 10b5-1 plan | SELL | $57K 3,329 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 62 | Karellis NikolaosDirector |  SBLKStar Bulk Carriers Corp.Open-market purchase | BUY | $57K 2,000 sh | Sep 16, 2026 traded Sep 15, 2026 |
| 55 | Beaulier Jonathan MeadChief Revenue Officer |  SNOWSnowflake Inc.Open-market sale | SELL | $4.13M 12.3K sh | Sep 16, 2026 traded Sep 16, 2026 |
| 54 | Spyrou Symeonco CFO | SBLKStar Bulk Carriers Corp. Open-market purchase | BUY | $424K 15.0K sh | Sep 16, 2026 traded Sep 15, 2026 |
| 51 | Zhuang MingzheDirector |  IBEXIBEX LtdOpen-market sale | SELL | $221K 5,522 sh | Sep 16, 2026 traded Sep 15, 2026 |